Retroviral inhibition of cAMP-dependent protein kinase inhibits myelination but not schwann cell mitosis stimulated by interaction with neurons

Journal of Neuroscience

Volumn 20, Issue 10, 2000, Pages 3513-3521

  Howe, Douglas G ^a   McCarthy, Ken D ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

GFP; Mitosis; Myelin; Neuron glial interaction; PKA; PKI; Retrovirus; RI AB; Schwann

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; GLIAL FIBRILLARY ACIDIC PROTEIN; KT 5720; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE;

ARTICLE; CELL INTERACTION; CONTROLLED STUDY; ENZYME INHIBITION; GENE TARGETING; GLIA; HUMAN; HUMAN CELL; MITOSIS; MYELINATION; NERVE CELL; PRIORITY JOURNAL; RETROVIRUS; SCHWANN CELL; SPINAL GANGLION;

EID: 0034658336     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.20-10-03513.2000     Document Type: Article

References (45)

1. Bunge RP (1994) The role of the Schwann cell in trophic support and regeneration. J Neurol 242:S19-S21.
2. 2+-calmodulin-dependent protein kinase on neurite development in cultured rat hippocampal neurons. Int J Dev Neurosci 11:357-368.
3. Chijiwa T, Mishima A, Hagiwara M, Sano M, Hayashi K, Inoue T, Naito K, Toshioka T, Hidaka H (1990) Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J Biol Chem 265:5267-5272.
4. Corell LA, Woodford TA, Corbin JD, Mellon PL, McKnight GS (1989) Functional characterization of cAMP-binding mutations in type I protein kinase. J Biol Chem 264:16672-16678.
5. Davis JB, Stroobant P (1990) Platelet-derived growth factors and fibroblast growth factors are mitogenic for rat Schwann cells. J Cell Biol 110:1353-1360.
6. Fernandez-Valle C, Fregien N, Wood PM, Bunge MB (1993) Expression of the protein zero myelin gene in axon related Schwann cells is linked to basal lamina formation. Development 119:867-880.
7. Gupta SK, Poduslo JF, Dunn R, Roder J, Mezei C (1990) Myelin-associated glycoprotein gene expression in the presence and absence of Schwann cell-axonal contact. Dev Neurosci 12:22-33.
8. Gupta SK, Pringle J, Poduslo JF, Mezei C (1993) Induction of myelin genes during peripheral nerve remyelination requires a continuous signal from the ingrowing axon. J Neurosci Res 34:14-23.
9. Hayasaka K, Himoro M, Sato W, Takada G, Uyemura K, Shimizu N, Bird TD, Conneally PM, Chence PF (1993) Charcot-Marie-Tooth neuropathy type 1B is associated with mutations of the myelin Pl gene. Nat Genet 5:31-34.
10. Herberg FW, Taylor SS (1993) Physiological inhibitors of the catalytic subunit of cAMP-dependent protein kinase: effect of MgATP on protein-protein interactions. Biochemistry 32:14015-14022.
11. Hofmann F (1980) Apparent constants for the interaction of regulatory and catalytic subunit of cAMP-dependent protein kinase I and II. J Biol Chem 255:1559-1564.
12. Howe DG, McCarthy KD (1998) A dicistronic retroviral vector and culture model for analysis of neuron-Schwann cell interactions. J Neurosci Methods 83:133-142.
13. Kase H, Iwahashi K, Nakanishi S, Matsuda Y, Yamada K, Takahashi M, Murakata C, Sato A, Kaneko M (1987) K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem Biophys Res Commun 142:436-440.
14. Kawasaki H, Springett GM, Mochizuki N, Toki S, Nakaya M, Matsuda M, Housman DE, Graybiel AM (1998) A family of cAMP-binding proteins that directly activate Rap1. Science 282:2275-2279.
15. Kim HA, DeClue JE, Ratner N (1997) cAMP-dependent protein kinase A is required for Schwann cell growth: interactions between the cAMP and neuregulin tyrosine kinase pathways. J Neurosci Res 49:236-247.
16. Kulkens T, Bolhuis PA, Wolterman RA, Kemp S, Te Nijenhuis S, Valentijn LJ, Hensels GW, Jennekens FG, DeVisser M, Hoogendijk JE, Baas F (1993) Deletion of the serine 34 codon from the major peripheral myelin protein Po gene in Charcot-Marie-Tooth disease type 1B. Nat Genet 5:35-39.
17. Lee MM, Badache A, DeVries GH (1999) Phosphorylation of CREB in axon-induced Schwann cell proliferation. J Neurosci Res 55:702-712.
18. Levi AD, Bunge RP, Lofgren JA, Meima L, Hefti F, Nikolics K, Sliwkowski MX (1995) The influence of heregulins on human Schwann cell proliferation. J Neurosci 15:1329-1340.
19. Marrosu MG, Vaccargiu S, Marrosu G, Vannelli A, Cianchetti C, Muntoni F (1998) Charcot-Marie-Tooth disease type 2 associated with mutation of the myelin protein zero gene. Neurology 50:1397-1401.
20. 3H]thymidine incorporation by primary cultures of highly purified non-neuronal cells. Brain Res 114:415-426.
21. McKnight GS, Cadd GG, Clegg CH, Otten AD, Correll LA (1988) Expression of wild-type and mutant subunits of the cAMP-dependent protein kinase. Cold Spring Harb Symp Quant Biol 53:111-119.
22. Mirsky R, Dubois C, Morgan L, Jessen KR (1990) 04 and A007-sulfatide antibodies bind to embryonic Schwann cells prior to the appearance of galactocerebroside; regulation of the antigen by axon-Schwann cell signals and cyclic AMP. Development 109:105-116.
23. - , GFAP-, N-CAM-, NGF-Receptor-) depends on growth inhibition. J Cell Biol 112:457-467.
24. Morrissey TK, Levi AD, Nuijens A, Sliwkowski MX, Bunge RP (1995) Axon-induced mitogenesis of human Schwann cells involves heregulin and p185erbB2. Proc Natl Acad Sci USA 92:1431-1435.
25. Muir D, Gennrich C, Varon S, Manthorpe M (1989) Rat sciatic nerve Schwann cell microcultures: responses to mitogens and production of trophic and neurite-promoting factors. Neurochem Res 14:1003-1012.
26. Oh S, Ri Y, Bennett MV, Trexler EB, Verselis VK, Bargiello TA (1997) Changes in permeability caused by connexin32 mutations underlie X-linked Charcot-Marie-Tooth disease. Neuron 19:927-938.
27. Ohtsuka T, Shimizu K, Yamamori B, Kuroda S, Takai Y (1996) Activation of brain B-Raf protein kinase by Rap1B small GTP-binding protein. J Biol Chem 271:1258-1261.
28. Olsen MK, Reszka AA, Abraham I (1998) KT5720 and U-98017 inhibit MAPK and alter the cytoskeleton and cell morphology. J Cell Physiol 176:525-536.
29. Poduslo JF, Walikonis RS, Domec MC, Berg CT, Holtz-Heppelmann CJ (1995) The second messenger, cyclic AMP, is not sufficient for myelin gene induction in the peripheral nervous system. J Neurochem 65:149-159.
30. Politis MJ, Sternberger N, Ederle K, Spencer PS (1982) Studies on the control of myelinogenesis. IV. Neuronal induction of Schwann cell myelin-specific protein synthesis during nerve fiber regeneration. J Neurosci 2:1252-1266.
31. Rahmatullah M, Schroering A, Rothblum K, Stahl RC, Urban B, Carey DJ (1998) Synergistic regulation of Schwann cell proliferation by heregulin and forskolin. Mol Cell Biol 18:6245-6252.
32. Salzer JL, Bunge RP (1980) Studies of Schwann cell proliferation. I. An analysis in tissue culture of proliferation during development. Wallerian degeneration, and direct injury. J Cell Biol 84:739-752.
33. Salzer JL, Bunge RP, Glaser L (1980) Studies of Schwann cell proliferation. III. Evidence for the surface localization of the neurite mitogen. J Cell Biol 84:767-778.
34. Scott JD, Glaccum MB, Fischer EH, Krebs EG (1986) Primary structure requirements for inhibition by the heat-stable inhibitor of the cAMP-dependent protein kinase. Proc Natl Acad Sci USA 83:1613-1616.
35. Shuman S, Hardy M, Sobue G, Pleasure D (1988) A cAMP analogue induces synthesis of myelin-specific glycoproteins by cultured Schwann cells. J Neurochem 50:190-194.
36. Sobue G, Pleasure D (1984) Schwann cell galactocerebroside induced by derivatives of adenosine 3',5'-monophosphate. Science 224:72-74.
37. Sohue G, Shuman S, Pleasure D (1986) Schwann cell responses to cyclic AMP: proliferation, change in shape, and appearance of surface galactocerebroside. Brain Res 362:23-32.
38. Stewart HJ, Eccleston PA, Jessen KR, Mirsky R (1991) Interaction between cAMP elevation, identified growth factors, and serum components in regulating Schwann cell growth. J Neurosci Res 30:346-352.
39. Tabernero A, Stewart HJS, Jessen KR, Mirsky R (1998) The neuronglia signal beta neuregulin induces sustained CREB phosphorylation on Ser-133 in cultured rat Schwann cells. Mol Cell Neurosci 10:309-322.
40. Walikonis RS, Poduslo JF (1998) Activity of cyclic AMP phosphodicsterases and adenylyl cyclase in peripheral nerve after crush and permanent transection injuries. J Biol Chem 273:9070-9077.
41. Wang X, Murphy TJ (1998) Inhibition of cyclic AMP-dependent kinase by expression of a protein kinase inhibitor/enhanced green fluorescent fusion protein attenuates angiotensin II-induced type 1 AT1 receptor mRNA down-regulation in vascular smooth muscle cells. Mol Pharmacol 54:514-524.
42. Weinmaster G, Lemke G (1990) Cell-specific cyclic AMP-mediated induction of the PDGF receptor. EMBO J 9:915-920.
43. Woodford TA, Correll LA, McKnight GS, Corbin JD (1989) Expression and characterization of mutant forms of the type I regulatory subunit of cAMP-dependent protein kinase. The effect of defective cAMP binding on holoenzyme activation. J Biol Chem 264:13321-13328.
44. York RD, Yao H, Dillon T, Ellig CL, Eckert SP, McCleskey EW, Stork PJ (1998) Rap1 mediates sustained MAP kinase activation induced by nerve growth factor. Nature 392:622-626.
45. Zolotukhin S, Potter M, Hauswirth WW, Guy J, Muzyczka N (1996) A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells. J Virol 70:4646-4654.